BB - Société BIC SA
PAR
->
Consumer Defensive
->
Household & Personal Products
Clichy,
France
Type: Equity
BB price evolution
BB
| (in millions $) | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 | 1 May 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $175 | $172 | $224 | |
| Inventory | ||||
| Total current assets | $438 | $458 | $508 | |
| Long term investments | ||||
| Property, plant & equipment | $49 | $46 | $53 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1299 | $1323 | $1395 | |
| Current liabilities | ||||
| Accounts payable | $7 | $6 | $17 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $305 | $321 | $356 | |
| Long term debt | $195 | $194 | $194 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $567 | $581 | $619 | |
| Shareholders' equity | ||||
| Retained earnings | -$2219 | -$2200 | -$2158 | |
| Other shareholder equity | -$13 | -$15 | -$14 | |
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2025 | 31 Jan 2024 | 28 Mar 2023 | 28 Mar 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $224 | $135 | $172 | |
| Inventory | ||||
| Total current assets | $508 | $743 | $1043 | |
| Long term investments | ||||
| Property, plant & equipment | $53 | $69 | $91 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1395 | $1679 | $2567 | |
| Current liabilities | ||||
| Accounts payable | $17 | $24 | $22 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $356 | $729 | $397 | |
| Long term debt | $194 | $507 | ||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $619 | $822 | $1011 | |
| Shareholders' equity | ||||
| Retained earnings | -$2158 | -$2028 | -$1294 | |
| Other shareholder equity | -$14 | -$18 | -$11 | |
| Total shareholder equity | ||||
| (in millions $) | 30 Oct 2025 | 30 Jul 2025 | 31 Jan 2025 | 30 Oct 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 28 Mar 2023 | 28 Mar 2022 | 27 Mar 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $656 | $718 | $893 | |
| Cost of revenue | ||||
| Gross Profit | $419 | $467 | $643 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $494 | $468 | $1707 | |
| Operating income | -$1064 | |||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $14 | $7 | -$9 | |
| Interest expense | $5 | $20 | ||
| Net income | ||||
| Net income | -$734 | $12 | -$1104 | |
| Income (for common shares) | ||||
| (in millions $) | 1 Oct 2024 | 1 Jul 2024 | 29 Mar 2024 | 30 Dec 2023 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $15 | -$26 | $46 | $112 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $1 | $1 | -$165 | -$211 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$12 | -$40 | -$122 | -$87 |
| (in millions $) | 29 Mar 2024 | 28 Mar 2023 | 28 Mar 2022 | 27 Mar 2021 |
|---|---|---|---|---|
| Net income | -$1104 | |||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $82 | |||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | $46 | $176 | $207 | -$65 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | -$165 | $6 | $10 | -$227 |
| Effect of exchange rate | -$3 | -$1 | $2 | |
| Change in cash and equivalents | -$122 | -$84 | $188 | -$208 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |